Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer.
Frontiers in immunology（2023）
摘要
Taken together, this novel cancer vaccination strategy following early surgical resection could be a promising therapeutic avenue for TNBC patients.
更多查看译文
关键词
Immunogenic cancer vaccine,immune effector cells,oncolytic virotherapy,triple negative breast cancer,tumor microenvironment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要